Head to head

Venus Versa Pro vs V30 (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: Catalog new-price ranges: Venus Versa Pro, $100k–$130k; V30, $50k–$80k. Check the source notes and request current quotes.
Technology: Venus Versa Pro: IPL. V30: Diode laser.
Practice fit: Both are listed under IPL multi-app platform. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

IPL multi-app platform

View full device profile →

Device B

IPL multi-app platform

View full device profile →

Price comparison

Price comparison: Venus Versa Pro vs Viora V30
Attribute	Venus Versa Pro	Viora V30
New price range	$100k–$130kSource not documented	$50k–$80kSource not documented
Used asking range	Not published	$20k–$35kSource not documented
Payback calculator	View ROI calculator	View ROI calculator
Next step

New price range

Venus Versa Pro: $100k–$130kSource not documented
Viora V30: $50k–$80kSource not documented

Used asking range

Venus Versa Pro: Not published
Viora V30: $20k–$35kSource not documented

Payback calculator

Venus Versa Pro: View ROI calculator
Viora V30: View ROI calculator

Next step

Venus Versa Pro

Viora V30

Consumable economics

Consumable economics: Venus Versa Pro vs Viora V30
Attribute	Venus Versa Pro	Viora V30
Consumable cost / lock-in	—	—
Service cost	Not published	Not published

Consumable cost / lock-in

Venus Versa Pro: —
Viora V30: —

Service cost

Venus Versa Pro: Not published
Viora V30: Not published

FDA clearance

FDA clearance: Venus Versa Pro vs Viora V30
Attribute	Venus Versa Pro	Viora V30
FDA status & indication	FDA ClearedK232192 Read FDA indication wording “The Venus Versa PRO System is a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 IPL applicators are indicated for the following: • Treatment of benign pigmented epidermal and cutaneous lesions including: hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, and cafe-au-lait macules. • Treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, angiomas and spider angiomas, poikiloderma of civatte, leg veins and venous malformations. The HR650, HR690, HR650XL, and HR690XL IPL applicators are indicated for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for skin types I-IV. Permanent hair reduction is defined as the longterm stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Venus Concept ACDUAL applicator is intended to be used for the treatment of acne vulgaris. The Diamondpolar and Octipolar applicators are non-invasive devices intended for use in dermatologic and general surgery procedures for females for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The Viva MD applicator is intended for dermatological procedures requiring ablation and resurfacing of the skin.”	FDA ClearedK133837 Read FDA indication wording “The Viora V-total 7"' isintended for dermatological procedures. The ST handpiece is indicated for the treatment of relief of minor muscle aches and pain, relief of muscle spasm and temporary improvement of local blood circulation. The IPL handpiece with wavelengths 415-l200nm (with 5 different filters) is indicated for the treatment of:. * Moderate inflammatory acne vulgaris. * Benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasrna, and ephelides (freckles). * Cutaneous lesions including warts, scars and striae. "Benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacca, erythema of rosacca, angiomnas and spider angiomnas, poikiloderma of Civatte and venous malformations. * Removal unwanted hair. It is also intended for permanent reduction in unwanted hair. Permanent hair reduction is defined as the long-term stable reduction inthe number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Nd:YAG Laser handpiece with wavelength 1064 nm comes with 4 different applicator spot diameters: 2x4, 3.5, 5.5 and 9.5 mm. The three smaller spot sizes (2x4, 3.5, 5.5 mm) are intended for: - Benign vascular lesions such as, but not limited to treatment of: port wine stains, hemangiomas, Warts, superficial and deep telangiectasias (venulectasias). reticular veins (0. 1-4.0mmn dia.) of the leg, rosace, venus lake, leg veins, spider veins, poikiloderma of civatte and angiomas. * Benign cutaneous lesions, such as, but not limited to: warts, scars, striae and psoriasis. * Benign pigmented lesions such as, but not limited to: lentigos (age spots), solar lentigos (sun spots), cafe-aulait macules, seborrheic keratosis, nevi and nevus of One, chloasma, verrucae, skin tags and keratosis. - Pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. ' The non-ablative treatment of facial wrinkles, such as, but not limited to: periocular wrinkles and perioral wrinkles. "The handpiece with a spot size of 9.5 mm is also intended for treatment of: Laser skin resurfacing procedures for the treatment of: acne scars and wrinkles. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral pant of the scar.”

FDA status & indication

Venus Versa Pro: FDA ClearedK232192
Read FDA indication wording
“The Venus Versa PRO System is a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 IPL applicators are indicated for the following: • Treatment of benign pigmented epidermal and cutaneous lesions including: hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, and cafe-au-lait macules. • Treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, angiomas and spider angiomas, poikiloderma of civatte, leg veins and venous malformations. The HR650, HR690, HR650XL, and HR690XL IPL applicators are indicated for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for skin types I-IV. Permanent hair reduction is defined as the longterm stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Venus Concept ACDUAL applicator is intended to be used for the treatment of acne vulgaris. The Diamondpolar and Octipolar applicators are non-invasive devices intended for use in dermatologic and general surgery procedures for females for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The Viva MD applicator is intended for dermatological procedures requiring ablation and resurfacing of the skin.”
Viora V30: FDA ClearedK133837
Read FDA indication wording
“The Viora V-total 7"' isintended for dermatological procedures. The ST handpiece is indicated for the treatment of relief of minor muscle aches and pain, relief of muscle spasm and temporary improvement of local blood circulation. The IPL handpiece with wavelengths 415-l200nm (with 5 different filters) is indicated for the treatment of:. * Moderate inflammatory acne vulgaris. * Benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasrna, and ephelides (freckles). * Cutaneous lesions including warts, scars and striae. "Benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacca, erythema of rosacca, angiomnas and spider angiomnas, poikiloderma of Civatte and venous malformations. * Removal unwanted hair. It is also intended for permanent reduction in unwanted hair. Permanent hair reduction is defined as the long-term stable reduction inthe number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Nd:YAG Laser handpiece with wavelength 1064 nm comes with 4 different applicator spot diameters: 2x4, 3.5, 5.5 and 9.5 mm. The three smaller spot sizes (2x4, 3.5, 5.5 mm) are intended for: - Benign vascular lesions such as, but not limited to treatment of: port wine stains, hemangiomas, Warts, superficial and deep telangiectasias (venulectasias). reticular veins (0. 1-4.0mmn dia.) of the leg, rosace, venus lake, leg veins, spider veins, poikiloderma of civatte and angiomas. * Benign cutaneous lesions, such as, but not limited to: warts, scars, striae and psoriasis. * Benign pigmented lesions such as, but not limited to: lentigos (age spots), solar lentigos (sun spots), cafe-aulait macules, seborrheic keratosis, nevi and nevus of One, chloasma, verrucae, skin tags and keratosis. - Pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. ' The non-ablative treatment of facial wrinkles, such as, but not limited to: periocular wrinkles and perioral wrinkles. "The handpiece with a spot size of 9.5 mm is also intended for treatment of: Laser skin resurfacing procedures for the treatment of: acne scars and wrinkles. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral pant of the scar.”

Which chains run each

Which chains run each: Venus Versa Pro vs Viora V30
Attribute	Venus Versa Pro	Viora V30
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

Venus Versa Pro: 0 recorded pairings
Viora V30: 0 recorded pairings

Chains using it

Venus Versa Pro: —
Viora V30: —

Approved reviews

Venus Versa Pro: 0
Viora V30: 0

Specs and platform

Specs and platform: Venus Versa Pro vs Viora V30
Attribute	Venus Versa Pro	Viora V30
Manufacturer	Venus Concept	Viora
Built by (OEM)	Venus Concept Inc.	Viora Ltd.
Category	IPL multi-app platform	IPL multi-app platform
Technology	Updated IPL/HR multi-app (IPL)	V-IPL + diode + RF modular (Diode laser)
Launch year	2023	2018
Status	Current	Current
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

Venus Versa Pro: Venus Concept
Viora V30: Viora

Built by (OEM)

Venus Versa Pro: Venus Concept Inc.
Viora V30: Viora Ltd.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

InMode Envision

IPL multi-app platform

New: —

Lumenis Stellar M22

IPL multi-app platform

New: $90k–$130k

InMode Optimas

IPL multi-app platform

New: $90k–$130k

SharpLight OmniMax S4

IPL multi-app platform

New: $60k–$90k

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.